Supply Chain

As health systems and hospitals crawl back to positive finances after 2022 swept many into the red, Kaiser Permanente's supply chain unit is focused on managing inflation through better understanding and tracking. 

The FDA issued a warning letter to iRhythm Technologies after inspectors found faults with how one of its facilities makes its heart monitors.

The FDA is deciding whether to temporarily allow the importation of chemotherapy drugs from unapproved manufacturers outside of the U.S. as the nation grapples with a shortage of key cancer drugs, a spokesperson with the agency told CNBC June 1. 

Tomorrow Health, a home-based care technology company based in New York City, shuttered its home medical equipment supply company in late May. 

With 268 recalls, the second quarter of 2022 hit the record of the highest number of recalled medical devices since 2020, according to an industry report from Sedgwick. 

The Center for U.S. Policy is asking the FDA to deem Bamboo Health's pharmaceutical software NarxCare as a misbranded product. 

FDA officials are warning that medical device shortages could worsen now that the public health emergency has expired because with its end a requirement for medical device companies to notify the agency of shortages also ceased. 

Draeger Medical, or Dräger US, recalled more than half a million airway devices because of a manufacturing error that can lead to hypoxia and death, the FDA said May 24. 

New York-based Northwell Health is training healthcare professionals to identify and address forced labor in the medical supply chain.

Vanderbilt University Medical Center and medical devicemaker Philips teamed up to reduce the Nashville, Tenn.-based system's carbon footprint.